GSK3β is a key regulator of the ROS-dependent necrotic death induced by the quinone DMNQ

Abstract

Signaling pathways controlling necrosis are still mysterious and debated. We applied a shRNA-based viability screen to identify critical elements of the necrotic response. We took advantage from a small molecule (G5) that makes covalent adducts with free thiols by Michael addition and elicits multiple stresses. In cells resistant to apoptosis, G5 triggers necrosis through the induction of protein unfolding, glutathione depletion, ER stress, proteasomal impairments, and cytoskeletal stress. The kinase GSK3β was isolated among the top hits of the screening. Using the quinone DMNQ, a ROS generator, we demonstrate that GSK3β is involved in the regulation of ROS-dependent necrosis. Our results have been validated using siRNA and by knocking-out GSK3β with the CRISPR/Cas9 technology. In response to DMNQ GSK3β is activated by serine 9 dephosphorylation, concomitantly to Akt inactivation. During the quinone-induced pronecrotic stress, GSK3β gradually accumulates into the nucleus, before the collapse of the mitochondrial membrane potential. Accumulation of ROS in response to DMNQ is impaired by the absence of GSK3β. We provide evidence that the activities of the obligatory two-electrons reducing flavoenzymes, NQO1 (NAD(P)H quinone dehydrogenase 1) and NQO2 are required to suppress DMNQ-induced necrosis. In the absence of GSK3β the expression of NQO1 and NQO2 is dramatically increased, possibly because of an increased transcriptional activity of NRF2. In summary, GSK3β by blunting the anti-oxidant response and particularly NQO1 and NQO2 expression, favors the appearance of necrosis in response to ROS, as generated by the quinone DMNQ.

Glycogen synthesis and beyond, a comprehensive review of GSK3 as a key regulator of metabolic pathways and a therapeutic target for treating metabolic diseases

“…Notably, GSK3 activity was increased by ROS in multiple cell types, and this increase is important for ROS-induced cell death in damaged/injured tissue, including heart, neuron, and liver. [200][201][202][203][204] These studies provide some evidence for potential positive feedback between ROS and GSK3 that controls cell death (Figure 3).…”

Proteotoxic Stress and Cell Death in Cancer Cells

“…How these events integrate with classic apoptotic signaling is not clear. In some studies, induction of oxidative stress can be observed in the initial phases of proteotoxic stress [84,151,152]. Certainly, the augmented levels of ROS and calcium can be responsible for the induction of alternative forms of death in response to the proteotoxic stress observed in different studies [153,154].…”

Insulin Resistance Exacerbates Alzheimer Disease via Multiple Mechanisms

“…As mentioned above, insulin resistance causes production of ROS via the activation of the AGE/RAGE pathway, inducing various stress sensitive signaling pathways, such as NF-κB, JNK/SAPK, p38 MAPK, and Akt pathway in particular ( Rains and Jain, 2011 ). Increased oxidative stress inactivates the Akt pathway, concomitantly to downstream activation of GSK3 and subsequent hyperphosphorylation of tau protein ( Bloch-Damti and Bashan, 2005 ; Hambright et al, 2015 ; Zhao et al, 2017 ; Ciotti et al, 2020 ).…”